Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α

Journal of Experimental Medicine

Volumn 199, Issue 5, 2004, Pages 731-736

  Boyman, Onur ^a,d   Hefti, Hans Peter ^a,c   Conrad, Curdin ^a   Nickoloff, Brian J ^b   Suter, Mark ^c   Nestle, Frank O ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Immunotherapy; Inflammation; Mouse model; Skin

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD83 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON RECEPTOR; INTERLEUKIN 12; KI 67 ANTIGEN; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; CELL DIVISION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHENOTYPE; PSORIASIS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542313881     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031482     Document Type: Article

References (25)

1. Griffiths, C.E., and J.J. Voorhees. 1996. Psoriasis, T cells and autoimmunity. J. R. Soc. Med. 89:315-319.
2. Krueger, J.G. 2002. The immunologic basis for the treatment of psoriasis with new biologic agents. J. Am. Acad. Dermatol. 46:1-23.
3. Barker, J.N. 1991. The pathophysiology of psoriasis. Lancet. 338:227-230.
4. Gottlieb, S.L., P. Gilleaudeau, R. Johnson, L. Estes, T.G. Woodworth, A.B. Gottlieb, and J.G. Krueger. 1995. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat. Med. 1:442-447.
5. Ellis, C.N., and G.G. Krueger. 2001. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N. Engl. J. Med. 345:248-255.
6. Christophers, E. 1996. The immunopathology of psoriasis. Int. Arch. Allergy Immunol. 110:199-206.
7. Wrone-Smith, T., and B.J. Nickoloff. 1996. Dermal injection of immunocytes induces psoriasis. J. Clin. Invest. 98:1878-1887.
8. Boehncke, W.H., D. Dressel, T.M. Zollner, and R. Kaufmann. 1996. Pulling the trigger on psoriasis. Nature. 379:777.
9. Schon, M.P., M. Detmar, and C.M. Parker. 1997. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat. Med. 3:183-188.
10. Biron, C.A., K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
11. Fernandez, N.C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405-411.
12. Ashkar, A.A., J.P. Di Santo, and B.A. Croy. 2000. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192:259-270.
13. Gourlay, W.A., W.H. Chambers, A.P. Monaco, and T. Maki. 1998. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation. 65:727-734.
14. Grob, P., V.E. Schijns, M.F. van den Broek, S.P. Cox, M. Ackermann, and M. Suter. 1999. Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. J. Virol. 73:4748-4754.
15. Lee, C.K., D.T. Rao, R. Gertner, R. Gimeno, A.B. Frey, and D.E. Levy. 2000. Distinct requirements for IFNs and STAT1 in NK cell function. J. Immunol. 165:3571-3577.
16. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921.
17. Fraki, J.E., R.A. Briggaman, and G.S. Lazarus. 1983. Transplantation of psoriatic skin onto nude mice. J. Invest. Dermatol. 80:31s-35s.
18. Baker, B.S., A.F. Swain, H. Valdimarsson, and L. Fry. 1984. T-cell subpopulations in the blood and skin of patients with psoriasis. Br. J. Dermatol. 110:37-44.
19. Surh, C.D., and J. Sprent. 2000. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J. Exp. Med. 192:F9-F14.
20. Westermann, J., B. Engelhardt, and J.C. Hoffmann. 2001. Migration of T cells in vivo: molecular mechanisms and clinical implications. Ann. Intern. Med. 135:279-295.
21. Nickoloff, B.J., G.D. Karabin, J.N. Barker, C.E. Griffiths, V. Sarma, R.S. Mitra, J.T. Elder, S.L. Kunkel, and V.M. Dixit. 1991. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am. J. Pathol. 138:129-140.
22. Adorini, L., and F. Sinigaglia. 1997. Pathogenesis and immunotherapy of autoinunune diseases. Immunol. Today. 18:209-211.
23. Chaudhari, U., P. Romano, L.D. Mulcahy, L.T. Dooley, D.G. Baker, and A.B. Gottlieb. 2001. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 357:1842-1847.
24. Mease, P.J., B.S. Goffe, J. Metz, A. VanderStoep, B. Finck, and D.J. Burge. 2000. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 356:385-390.
25. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.